Global Needle-Free Influenza Vaccine Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Needle-Free Influenza Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Needle-Free Influenza Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Needle-Free Influenza Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Needle-Free Influenza Vaccine Segment by Type

2.2.1 Live Attenuated Influenza Vaccine

2.2.2 Split Influenza Vaccine

2.3 Needle-Free Influenza Vaccine Sales by Type

2.3.1 Global Needle-Free Influenza Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Needle-Free Influenza Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Needle-Free Influenza Vaccine Sale Price by Type (2017-2022)

2.4 Needle-Free Influenza Vaccine Segment by Application

2.4.1 3-17 Years

2.4.2 Others

2.5 Needle-Free Influenza Vaccine Sales by Application

2.5.1 Global Needle-Free Influenza Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Needle-Free Influenza Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Needle-Free Influenza Vaccine Sale Price by Application (2017-2022)

3 Global Needle-Free Influenza Vaccine by Company

3.1 Global Needle-Free Influenza Vaccine Breakdown Data by Company

3.1.1 Global Needle-Free Influenza Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Needle-Free Influenza Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Needle-Free Influenza Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Needle-Free Influenza Vaccine Revenue by Company (2020-2022)

3.2.2 Global Needle-Free Influenza Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Needle-Free Influenza Vaccine Sale Price by Company

3.4 Key Manufacturers Needle-Free Influenza Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Needle-Free Influenza Vaccine Product Location Distribution

3.4.2 Players Needle-Free Influenza Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Needle-Free Influenza Vaccine by Geographic Region

4.1 World Historic Needle-Free Influenza Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Needle-Free Influenza Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Needle-Free Influenza Vaccine Annual Revenue by Geographic Region

4.2 World Historic Needle-Free Influenza Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Needle-Free Influenza Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Needle-Free Influenza Vaccine Annual Revenue by Country/Region

4.3 Americas Needle-Free Influenza Vaccine Sales Growth

4.4 APAC Needle-Free Influenza Vaccine Sales Growth

4.5 Europe Needle-Free Influenza Vaccine Sales Growth

4.6 Middle East & Africa Needle-Free Influenza Vaccine Sales Growth

5 Americas

5.1 Americas Needle-Free Influenza Vaccine Sales by Country

5.1.1 Americas Needle-Free Influenza Vaccine Sales by Country (2017-2022)

5.1.2 Americas Needle-Free Influenza Vaccine Revenue by Country (2017-2022)

5.2 Americas Needle-Free Influenza Vaccine Sales by Type

5.3 Americas Needle-Free Influenza Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Needle-Free Influenza Vaccine Sales by Region

6.1.1 APAC Needle-Free Influenza Vaccine Sales by Region (2017-2022)

6.1.2 APAC Needle-Free Influenza Vaccine Revenue by Region (2017-2022)

6.2 APAC Needle-Free Influenza Vaccine Sales by Type

6.3 APAC Needle-Free Influenza Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Needle-Free Influenza Vaccine by Country

7.1.1 Europe Needle-Free Influenza Vaccine Sales by Country (2017-2022)

7.1.2 Europe Needle-Free Influenza Vaccine Revenue by Country (2017-2022)

7.2 Europe Needle-Free Influenza Vaccine Sales by Type

7.3 Europe Needle-Free Influenza Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Needle-Free Influenza Vaccine by Country

8.1.1 Middle East & Africa Needle-Free Influenza Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Needle-Free Influenza Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Needle-Free Influenza Vaccine Sales by Type

8.3 Middle East & Africa Needle-Free Influenza Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Needle-Free Influenza Vaccine

10.3 Manufacturing Process Analysis of Needle-Free Influenza Vaccine

10.4 Industry Chain Structure of Needle-Free Influenza Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Needle-Free Influenza Vaccine Distributors

11.3 Needle-Free Influenza Vaccine Customer

12 World Forecast Review for Needle-Free Influenza Vaccine by Geographic Region

12.1 Global Needle-Free Influenza Vaccine Market Size Forecast by Region

12.1.1 Global Needle-Free Influenza Vaccine Forecast by Region (2023-2028)

12.1.2 Global Needle-Free Influenza Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Needle-Free Influenza Vaccine Forecast by Type

12.7 Global Needle-Free Influenza Vaccine Forecast by Application

13 Key Players Analysis

13.1 AstraZeneca

13.1.1 AstraZeneca Company Information

13.1.2 AstraZeneca Needle-Free Influenza Vaccine Product Offered

13.1.3 AstraZeneca Needle-Free Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 AstraZeneca Main Business Overview

13.1.5 AstraZeneca Latest Developments

13.2 Cipla

13.2.1 Cipla Company Information

13.2.2 Cipla Needle-Free Influenza Vaccine Product Offered

13.2.3 Cipla Needle-Free Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Cipla Main Business Overview

13.2.5 Cipla Latest Developments

13.3 BCHT

13.3.1 BCHT Company Information

13.3.2 BCHT Needle-Free Influenza Vaccine Product Offered

13.3.3 BCHT Needle-Free Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 BCHT Main Business Overview

13.3.5 BCHT Latest Developments

14 Research Findings and Conclusion

Table 1. Needle-Free Influenza Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Needle-Free Influenza Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Live Attenuated Influenza Vaccine

Table 4. Major Players of Split Influenza Vaccine

Table 5. Global Needle-Free Influenza Vaccine Sales by Type (2017-2022) & (K Dose)

Table 6. Global Needle-Free Influenza Vaccine Sales Market Share by Type (2017-2022)

Table 7. Global Needle-Free Influenza Vaccine Revenue by Type (2017-2022) & ($ million)

Table 8. Global Needle-Free Influenza Vaccine Revenue Market Share by Type (2017-2022)

Table 9. Global Needle-Free Influenza Vaccine Sale Price by Type (2017-2022) & (US$/Dose)

Table 10. Global Needle-Free Influenza Vaccine Sales by Application (2017-2022) & (K Dose)

Table 11. Global Needle-Free Influenza Vaccine Sales Market Share by Application (2017-2022)

Table 12. Global Needle-Free Influenza Vaccine Revenue by Application (2017-2022)

Table 13. Global Needle-Free Influenza Vaccine Revenue Market Share by Application (2017-2022)

Table 14. Global Needle-Free Influenza Vaccine Sale Price by Application (2017-2022) & (US$/Dose)

Table 15. Global Needle-Free Influenza Vaccine Sales by Company (2020-2022) & (K Dose)

Table 16. Global Needle-Free Influenza Vaccine Sales Market Share by Company (2020-2022)

Table 17. Global Needle-Free Influenza Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Needle-Free Influenza Vaccine Revenue Market Share by Company (2020-2022)

Table 19. Global Needle-Free Influenza Vaccine Sale Price by Company (2020-2022) & (US$/Dose)

Table 20. Key Manufacturers Needle-Free Influenza Vaccine Producing Area Distribution and Sales Area

Table 21. Players Needle-Free Influenza Vaccine Products Offered

Table 22. Needle-Free Influenza Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Needle-Free Influenza Vaccine Sales by Geographic Region (2017-2022) & (K Dose)

Table 26. Global Needle-Free Influenza Vaccine Sales Market Share Geographic Region (2017-2022)

Table 27. Global Needle-Free Influenza Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Needle-Free Influenza Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Needle-Free Influenza Vaccine Sales by Country/Region (2017-2022) & (K Dose)

Table 30. Global Needle-Free Influenza Vaccine Sales Market Share by Country/Region (2017-2022)

Table 31. Global Needle-Free Influenza Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Needle-Free Influenza Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Needle-Free Influenza Vaccine Sales by Country (2017-2022) & (K Dose)

Table 34. Americas Needle-Free Influenza Vaccine Sales Market Share by Country (2017-2022)

Table 35. Americas Needle-Free Influenza Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Needle-Free Influenza Vaccine Revenue Market Share by Country (2017-2022)

Table 37. Americas Needle-Free Influenza Vaccine Sales by Type (2017-2022) & (K Dose)

Table 38. Americas Needle-Free Influenza Vaccine Sales Market Share by Type (2017-2022)

Table 39. Americas Needle-Free Influenza Vaccine Sales by Application (2017-2022) & (K Dose)

Table 40. Americas Needle-Free Influenza Vaccine Sales Market Share by Application (2017-2022)

Table 41. APAC Needle-Free Influenza Vaccine Sales by Region (2017-2022) & (K Dose)

Table 42. APAC Needle-Free Influenza Vaccine Sales Market Share by Region (2017-2022)

Table 43. APAC Needle-Free Influenza Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Needle-Free Influenza Vaccine Revenue Market Share by Region (2017-2022)

Table 45. APAC Needle-Free Influenza Vaccine Sales by Type (2017-2022) & (K Dose)

Table 46. APAC Needle-Free Influenza Vaccine Sales Market Share by Type (2017-2022)

Table 47. APAC Needle-Free Influenza Vaccine Sales by Application (2017-2022) & (K Dose)

Table 48. APAC Needle-Free Influenza Vaccine Sales Market Share by Application (2017-2022)

Table 49. Europe Needle-Free Influenza Vaccine Sales by Country (2017-2022) & (K Dose)

Table 50. Europe Needle-Free Influenza Vaccine Sales Market Share by Country (2017-2022)

Table 51. Europe Needle-Free Influenza Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Needle-Free Influenza Vaccine Revenue Market Share by Country (2017-2022)

Table 53. Europe Needle-Free Influenza Vaccine Sales by Type (2017-2022) & (K Dose)

Table 54. Europe Needle-Free Influenza Vaccine Sales Market Share by Type (2017-2022)

Table 55. Europe Needle-Free Influenza Vaccine Sales by Application (2017-2022) & (K Dose)

Table 56. Europe Needle-Free Influenza Vaccine Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Needle-Free Influenza Vaccine Sales by Country (2017-2022) & (K Dose)

Table 58. Middle East & Africa Needle-Free Influenza Vaccine Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Needle-Free Influenza Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Needle-Free Influenza Vaccine Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Needle-Free Influenza Vaccine Sales by Type (2017-2022) & (K Dose)

Table 62. Middle East & Africa Needle-Free Influenza Vaccine Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Needle-Free Influenza Vaccine Sales by Application (2017-2022) & (K Dose)

Table 64. Middle East & Africa Needle-Free Influenza Vaccine Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Needle-Free Influenza Vaccine

Table 66. Key Market Challenges & Risks of Needle-Free Influenza Vaccine

Table 67. Key Industry Trends of Needle-Free Influenza Vaccine

Table 68. Needle-Free Influenza Vaccine Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Needle-Free Influenza Vaccine Distributors List

Table 71. Needle-Free Influenza Vaccine Customer List

Table 72. Global Needle-Free Influenza Vaccine Sales Forecast by Region (2023-2028) & (K Dose)

Table 73. Global Needle-Free Influenza Vaccine Sales Market Forecast by Region

Table 74. Global Needle-Free Influenza Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Needle-Free Influenza Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Needle-Free Influenza Vaccine Sales Forecast by Country (2023-2028) & (K Dose)

Table 77. Americas Needle-Free Influenza Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Needle-Free Influenza Vaccine Sales Forecast by Region (2023-2028) & (K Dose)

Table 79. APAC Needle-Free Influenza Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Needle-Free Influenza Vaccine Sales Forecast by Country (2023-2028) & (K Dose)

Table 81. Europe Needle-Free Influenza Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Needle-Free Influenza Vaccine Sales Forecast by Country (2023-2028) & (K Dose)

Table 83. Middle East & Africa Needle-Free Influenza Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Needle-Free Influenza Vaccine Sales Forecast by Type (2023-2028) & (K Dose)

Table 85. Global Needle-Free Influenza Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Needle-Free Influenza Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Needle-Free Influenza Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Needle-Free Influenza Vaccine Sales Forecast by Application (2023-2028) & (K Dose)

Table 89. Global Needle-Free Influenza Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Needle-Free Influenza Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Needle-Free Influenza Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 92. AstraZeneca Basic Information, Needle-Free Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 93. AstraZeneca Needle-Free Influenza Vaccine Product Offered

Table 94. AstraZeneca Needle-Free Influenza Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 95. AstraZeneca Main Business

Table 96. AstraZeneca Latest Developments

Table 97. Cipla Basic Information, Needle-Free Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 98. Cipla Needle-Free Influenza Vaccine Product Offered

Table 99. Cipla Needle-Free Influenza Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 100. Cipla Main Business

Table 101. Cipla Latest Developments

Table 102. BCHT Basic Information, Needle-Free Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 103. BCHT Needle-Free Influenza Vaccine Product Offered

Table 104. BCHT Needle-Free Influenza Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 105. BCHT Main Business

Table 106. BCHT Latest Developments

List of Figures

Figure 1. Picture of Needle-Free Influenza Vaccine

Figure 2. Needle-Free Influenza Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Needle-Free Influenza Vaccine Sales Growth Rate 2017-2028 (K Dose)

Figure 7. Global Needle-Free Influenza Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Needle-Free Influenza Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Live Attenuated Influenza Vaccine

Figure 10. Product Picture of Split Influenza Vaccine

Figure 11. Global Needle-Free Influenza Vaccine Sales Market Share by Type in 2021

Figure 12. Global Needle-Free Influenza Vaccine Revenue Market Share by Type (2017-2022)

Figure 13. Needle-Free Influenza Vaccine Consumed in 3-17 Years

Figure 14. Global Needle-Free Influenza Vaccine Market: 3-17 Years (2017-2022) & (K Dose)

Figure 15. Needle-Free Influenza Vaccine Consumed in Others

Figure 16. Global Needle-Free Influenza Vaccine Market: Others (2017-2022) & (K Dose)

Figure 17. Global Needle-Free Influenza Vaccine Sales Market Share by Application (2017-2022)

Figure 18. Global Needle-Free Influenza Vaccine Revenue Market Share by Application in 2021

Figure 19. Needle-Free Influenza Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Needle-Free Influenza Vaccine Revenue Market Share by Company in 2021

Figure 21. Global Needle-Free Influenza Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Needle-Free Influenza Vaccine Revenue Market Share by Geographic Region in 2021

Figure 23. Global Needle-Free Influenza Vaccine Sales Market Share by Region (2017-2022)

Figure 24. Global Needle-Free Influenza Vaccine Revenue Market Share by Country/Region in 2021

Figure 25. Americas Needle-Free Influenza Vaccine Sales 2017-2022 (K Dose)

Figure 26. Americas Needle-Free Influenza Vaccine Revenue 2017-2022 ($ Millions)

Figure 27. APAC Needle-Free Influenza Vaccine Sales 2017-2022 (K Dose)

Figure 28. APAC Needle-Free Influenza Vaccine Revenue 2017-2022 ($ Millions)

Figure 29. Europe Needle-Free Influenza Vaccine Sales 2017-2022 (K Dose)

Figure 30. Europe Needle-Free Influenza Vaccine Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Needle-Free Influenza Vaccine Sales 2017-2022 (K Dose)

Figure 32. Middle East & Africa Needle-Free Influenza Vaccine Revenue 2017-2022 ($ Millions)

Figure 33. Americas Needle-Free Influenza Vaccine Sales Market Share by Country in 2021

Figure 34. Americas Needle-Free Influenza Vaccine Revenue Market Share by Country in 2021

Figure 35. United States Needle-Free Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Needle-Free Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Needle-Free Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Needle-Free Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Needle-Free Influenza Vaccine Sales Market Share by Region in 2021

Figure 40. APAC Needle-Free Influenza Vaccine Revenue Market Share by Regions in 2021

Figure 41. China Needle-Free Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Needle-Free Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Needle-Free Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Needle-Free Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Needle-Free Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Needle-Free Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Needle-Free Influenza Vaccine Sales Market Share by Country in 2021

Figure 48. Europe Needle-Free Influenza Vaccine Revenue Market Share by Country in 2021

Figure 49. Germany Needle-Free Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Needle-Free Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Needle-Free Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Needle-Free Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Needle-Free Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Needle-Free Influenza Vaccine Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Needle-Free Influenza Vaccine Revenue Market Share by Country in 2021

Figure 56. Egypt Needle-Free Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Needle-Free Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Needle-Free Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Needle-Free Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Needle-Free Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Needle-Free Influenza Vaccine in 2021

Figure 62. Manufacturing Process Analysis of Needle-Free Influenza Vaccine

Figure 63. Industry Chain Structure of Needle-Free Influenza Vaccine

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles